IFP Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

IFP Advisors’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1	Closed	-$71	–	4707
2024 Q4	$71	Buy	+1	New	+$70	﹤0.01%	4149
2023 Q1	–	Sell	-24	Closed	-$1K	–	4525
2022 Q4	$1K	Sell	24 -26	-52%	-$1.73K	﹤0.01%	4536
2022 Q3	$2K	Buy	50 +26	+108%	+$1.79K	﹤0.01%	4441
2022 Q2	$1K	Hold	24	–	–	﹤0.01%	4495
2022 Q1	$1K	Buy	+24	New	+$1.29K	﹤0.01%	4493
2020 Q3	–	Sell	-356	Closed	-$14.9K	–	3030
2020 Q2	$12K	Hold	356	–	–	﹤0.01%	1766
2020 Q1	$8K	Hold	356	–	–	﹤0.01%	1901
2019 Q4	$9K	Hold	356	–	–	﹤0.01%	1980
2019 Q3	$10K	Buy	+356	New	+$12.4K	﹤0.01%	2097

IFP Advisors's AXNX Position: Q1 2025 in Review

IFP Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2025, closing a stake of 1 share — an estimated $71 sold.

IFP Advisors first reported a position in AXNX in Q3 2019 and held it in 9 quarters. The position peaked at $12K in Q2 2020. 0 funds tracked by Wall St. Rank hold AXNX as of Q1 2025.

IFP Advisors reported no remaining Axonics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
IFP Advisors sold 1 Axonics, Inc. Common Stock share in Q1 2025, an estimated $71.
IFP Advisors first reported a position in Axonics, Inc. Common Stock in Q3 2019 and held it in 9 quarters.
IFP Advisors's Axonics, Inc. Common Stock position peaked at $12K in Q2 2020.
0 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2025.

Based on IFP Advisors's 13F filing for Q1 2025, filed 5 May 2025.